Compare Humana Inc (HUM) vs T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs T-Rex 2X Inverse MSTR Daily Target ETF — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while T-Rex 2X Inverse MSTR Daily Target ETF trades at $11.03. The key difference: Humana Inc pays a 0.92% dividend while T-Rex 2X Inverse MSTR Daily Target ETF pays none, and Humana Inc is trading nearer its 52-week high, T-Rex 2X Inverse MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals.
| HUM | MSTZ | |
|---|---|---|
Market Cap | $46.31B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $409.42 | $27.92 |
52-Week Low | $163.67 | $3.88 |
Enterprise Value | $53.67B | — |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
MSTZ's stock is currently trading at $10.3, down 6.19% over the past 24 hours, reflecting significant bearish pressure. Technical indicators are predominantly bearish, with moving averages signaling a downtrend and key support levels identified near $9 and $8. The absence of reported financial ratios such as P/E and P/S limits fundamental clarity, while recent news highlights ETF performance unrelated to the company's core business, indicating a lack of direct catalysts.
The outlook for MSTZ appears cautious due to weak technical momentum and limited fundamental visibility. Investment opportunities are constrained by the bearish signal and absence of recent financial data, posing risks from market volatility and potential competitive pressures. Investors should seek updated earnings reports for a clearer assessment of the company's financial health and growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About T-Rex 2X Inverse MSTR Daily Target ETF
MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →
